Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.
Front Pharmacol. 2022 Jan 28;12:797541. doi: 10.3389/fphar.2021.797541. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35153755
Free PMC article.
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases.
Solés-Tarrés I, Cabezas-Llobet N, Vaudry D, Xifró X.
Solés-Tarrés I, et al.
Front Cell Neurosci. 2020 Jul 17;14:221. doi: 10.3389/fncel.2020.00221. eCollection 2020.
Front Cell Neurosci. 2020.
PMID: 32765225
Free PMC article.
Item in Clipboard
Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
Vidal-Sancho L, Fernández-García S, Solés-Tarrés I, Alberch J, Xifró X.
Vidal-Sancho L, et al. Among authors: soles tarres i.
Mol Neurobiol. 2020 Nov;57(11):4549-4562. doi: 10.1007/s12035-020-02041-x. Epub 2020 Aug 5.
Mol Neurobiol. 2020.
PMID: 32757160
Item in Clipboard
Cite
Cite